Proc Natl Acad Sci U S A 2010 107146418-23. doRhead B Baarnhielm M Gianfrancesco M Mok A Shao X Quach H et al.

Nature 2013 4967446518-22. doi10.1038 nature11868Nourbakhsh B Graves J Casper TC Lulu S Waldman A Belman A et al.

5.3055Liepe J Marino F Sidney J Jeko A Bunting DE Sette A et al.

Proc Natl Acad Sci U S A 2015 1124313318-23. doBacklund J Treschow A Bockermann R Holm B Holm L Issazadeh- Navikas S et al.

J Immunol 2009 18364067-76. doKrishnamoorthy G Saxena A Mars LT Domingues HS Mentele R Ben- Nun A et al.

Arch Neurol 1999 562172-7. doLancaster E Huijbers MG Bar V Boronat A Wong A Martinez-Hernandez E et al.

Ann Neurol 2014 761108-19. doi10.1002 ana.24195Castillo-Gomez E Kastner A Steiner J Schneider A Hettling B Poggi G et al.

Neurotherapeutics 2016 131147-62. doDe Santis G Caniatti L De Vito A De Gennaro R Granieri E Tola MR. A possible paraneoplastic neuromyelitis optica associated with lung cancer.

A prototype is the anti-N-methyl- d-aspartate receptor NMDA receptor encephalitis in which the NMDA receptor is the target molecule of the immune responseTABLe 1  Human diseases and autoantigens main cellular expression and cellular compartment of expression as well as involved immune responses as presently known.A astrocytes AE autoimmune encephalitis C cytosol CS cytoskeleton E endosome ES extracellular space GA Golgi apparatus L lysosome M mitochondria MS multiple sclerosis N neurons N nucleus ND not determined NMOSD neuromyelitis optica spectrum disorder O oligodendrocytes P peroxisome PM plasma membrane U ubiquitous V vacuoles  positive findings - negative findings.It has been shown that antibodies are most important in this type of diseases and that these antibodies can lead to altera- tion of cellular function with consequences on behavior   or tissue destruction by complement .

Cell 1995 805695-705. doi10.10160092-867495 90348-8Weissert R Wallstrom E Storch MK Stefferl A Lorentzen J Lassmann H et al.

